Announced Mon, 6 Jul · 12:03 IST
Routine quarterly dematerialisation certificate filed with depositories
Compliance View source PDF
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.7%1-day move
₹127.25
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.7-4.9-4.5-7.1-3.2-5.2-6.6———
Up moveDown movePending
AI summary
Lotus Eye Hospital submitted the mandatory quarterly certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. Registrar MUFG Intime confirmed that all securities received for dematerialisation during the quarter were processed and that the underlying shares remain listed on BSE and NSE. This is a standard regulatory compliance filing.
Likely market impact
No business impact. Routine quarterly compliance filing with no effect on operations or shareholders.